24時間受付中
Zepbound (Tirzepatide) | Online Prescription | 2.5 mg from 6,000 JPY per pen | Consultation & Shipping Free
GIP/GLP-1 Receptor Agonist|Zepbound Injection
Zepbound (Tirzepatide)|Online Prescription|2.5 mg from 6,000 JPY per pen|Consultation & Shipping Free
Once-weekly self-injection to support weight management
- Nationwide delivery to your home
- Fully online flow through to prescription
- Once-weekly subcutaneous injection (2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg, stepwise titration)
- Alcohol swabs included / +2,000 JPY handling if purchasing only 1 pen
[Doctor’s Overview] What is “Zepbound”?
Zepbound (tirzepatide) is a dual agonist acting on both GLP-1 and GIP receptors. Used once weekly, it supports appetite control and post-meal glucose regulation, enabling sustainable weight management. Treatment starts at 2.5 mg and is escalated stepwise depending on tolerability. Always follow your physician’s instructions.
Targets GLP-1/GIP to naturally curb intake and improve glycemic control.
Use on the same weekday; easy to fit into busy schedules.
2.5 → 15 mg, adjusted with attention to GI symptoms and your profile.
Consultation & shipping are free. Nationwide delivery after payment.
Process to online prescription
Three simple steps on your phone. Same-day consults available; nationwide delivery.
How to use (follow your doctor’s instructions)
Remove from the refrigerator; check appearance and expiry. Clean the abdomen, thigh, or upper arm; rotate sites each time.
Press the pen vertically and inject as instructed. Keep pressed for a few seconds after the signal.
Start at 2.5 mg; escalate stepwise per tolerability. If GI symptoms are significant, consult your physician for adjustments.
Watch for nausea, vomiting, diarrhea/constipation, or abdominal pain. If severe symptoms occur, stop and seek care.
* Always follow your physician’s instructions and the official package insert.
Pricing
* Prices/stock may change. Please confirm in the online intake form.
Combination therapy (when appropriate)
Your physician may suggest add-ons based on your profile. Examples that can be synergistic:
Aim: Increase urinary glucose excretion to reduce net calories.
Best for: Frequent snacks / limited time to exercise.
Aim: Temper appetite impulses and support adherence.
Best for: Evening overeating / compulsive snacking.
Aim: Reduce hepatic gluconeogenesis and improve insulin resistance.
Best for: Higher fasting glucose / weight-neutral preference.
Aim: Support bowel movement and fluid balance—useful for constipation/edema patterns.
Best for: Constipation / edema / diet reset.
FAQ
Can I get Zepbound via online consultation?
How much does it cost?
When will it arrive?
Any storage tips?
Can I inject straight from the fridge?
Side effects?
Do I need a Japanese address or residence card?
Can I use a foreign credit card?
Can you ship to my hotel or Airbnb?
Can I consult before arriving in Japan?
I do not have a Japanese phone number. How can I have the consultation?
Can my family or friend in Japan receive the delivery on my behalf?
Can I get an English Doctor Letter for customs?
Can I order several months of supply at once?
Can I use this during pregnancy or breastfeeding?
What should I do if I miss a dose?
What if side effects are strong?
How is Zepbound different from Mounjaro?
How does Zepbound compare to Wegovy?
What is the dose titration schedule?
How soon will I see results?
About the Medicine We Prescribe (Zepbound)
Zepbound (tirzepatide) was PMDA-approved in Japan for obesity treatment in December 2024. Prescribed as self-pay treatment.
We use Eli Lilly Japan products obtained through licensed Japanese pharmaceutical wholesalers only. No personal imports or overseas sources.
Wegovy (semaglutide, 2023 approval for obesity), Mounjaro (tirzepatide, 2023 approval for type-2 diabetes).
FDA-approved (Nov 2023, US) for chronic weight management. Common side effects: nausea, diarrhea, vomiting, constipation, decreased appetite. Rare: pancreatitis, gallbladder disease.
Self-pay usage is NOT covered by Japan Adverse Drug Reaction Relief System.
Generic name: Tirzepatide / Class: GIP/GLP-1 receptor agonist / Form: Prefilled pen (single-dose) / Doses: 2.5/5/7.5/10/12.5/15 mg / YJ code: 2499420G1027. Refer to package insert for full information.
How Zepbound Works
Zepbound is a once-weekly injectable medicine for obesity treatment. Its active ingredient, tirzepatide, is a dual GIP/GLP-1 receptor agonist that provides stronger weight loss effect than GLP-1 alone. It was PMDA-approved in December 2024 for obesity treatment in Japan.
Reference: Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med 2022.
